Resalis Therapeutics
Alessandro Toniolo is the Chief Executive Officer e Amministratore Delegato at Resalis Therapeutics Srl, where Alessandro focuses on tackling metabolic disorders with non-coding RNAs. Alessandro is also a Business Angel at Italian Angels for Growth, championing various projects and companies. Prior to these roles, Alessandro has held positions at Novartis Italia, Shire, Pfizer, Merck Group, Menarini, and Eli Lilly, where Alessandro demonstrated expertise in various areas such as Immunology, Respiratory & Allergy, Oncology, and Genetic Diseases. Alessandro holds a Masters in Business from Scuola Superiore Sant'Anna and PHD degrees in Biophysical Chemistry and Chemistry from University of Illinois Urbana-Champaign and Università degli Studi di Milano respectively.
This person is not in any teams
This person is not in any offices
Resalis Therapeutics
1 followers
Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease. The company is applying its unique understanding of the non-coding RNA drug modality and lipid metabolism to develop its lead program, RES-010, into a safe and convenient treatment providing disease-modifying therapeutic impact including durable weight loss and reduction of hepatic steatosis. Building on robust preclinical evidence, Resalis will rapidly bring RES-010 into clinical trials for a range of metabolic disorders.